Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Share News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Ryanair hopeful for end of curbs, "gamechanger" jet

Mon, 17th May 2021 08:13

(Alliance News) - Ryanair Holdings fell to a loss of more than EUR1 billion in its most recently ended financial year but said Monday it expects an improvement as coronavirus restrictions ease and it introduces a more efficient airplane.

The Irish budget airline said it swung to a loss for the year to the end of March of EUR1.11 billion from EUR648.7 million profit recorded the year before.

Annual revenue fell 81% year-on-year to EUR1.64 billion from EUR8.49 billion, in line with the fall in traffic to just 27.5 million from 148.6 million the year prior. Load factor declined to 71% from 95% year-on-year.

Looking ahead, the company expects first-quarter traffic to be between 5 million and 6 million guests. It also believes that annual traffic is likely to be towards the lower end of its previously guided range of 80 million to 120 million passengers, which would represent a jump of up to four times year-on-year.

"With a very close-in booking curve, visibility for the remainder of FY22 is close to zero although bookings have jumped significantly from a very low base since week 1 of April," Ryanair said.

The airline said it thinks financial 2022 will be close to breakeven, assuming vaccine rollouts allow the lifting of intra-European travel restrictions in time for the July to September peak period.

Looking further ahead, Ryanair will benefit from introduction of the Boeing 737 "gamechanger" aircraft, which it said will improve revenue, with 4% more seats available, while reducing fuel costs.

Ryanair shares were up 2.0% early Monday in London.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.3% at 7,062.03

----------

Hang Seng: up 0.7% at 28,214.40

Nikkei 225: closed down 0.9% at 27,824.83

DJIA: closed up 360.68 points, or 1.1%, at 34,382.13

S&P 500: closed up 61.35 points, or 1.5%, at 4,173.85

Nasdaq Composite: closed up 304.99 points, or 2.3%, at 13,429.98

----------

EUR: flat at USD1.2140 (USD1.2138)

GBP: down at USD1.4001 (USD1.4088)

USD: down at JPY109.20 (JPY109.40)

GOLD: up at USD1,853.05 per ounce (USD1,837.50)

OIL (Brent): up at USD68.53 a barrel (USD68.30)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Monday's Key Economic Events still to come

0830 EDT US Empire State manufacturing survey

1000 EDT US NAHB housing market index

----------

UK Prime Minister Boris Johnson has called for a "heavy dose of caution" as indoor socialising and physical contact resumed against the backdrop of concerns over the Indian coronavirus variant. Johnson said "now everyone must play their part" as England pushed ahead with the third stage of the road map out of lockdown on Monday. Pubs and restaurants will be able to welcome customers back indoors, visits to the homes of friends and family can resume and the foreign holiday ban has ended. Hugs and other physical contact between households are also permitted for the first time since restrictions began more than a year ago. But the measures were eased as top scientists called for caution and warned of a "perilous moment", with the Indian variant feared to be as much as 50% more transmissible than the Kent strain.

----------

UK house prices notched another record high in May, property portal Rightmove said on Monday, as the sector continues its post-lockdown surge. UK house prices rose 1.8% monthly to an average of GBP333,564, a record high. Annually, prices are 6.7% higher. Rightmove noted that during housing market upturns in the UK, it is often London that leads the way. That is not the case this time, however, as house price growth in London since last year is just 0.2%. To compare, both the North West of England and Yorkshire & the Humber have seen growth of 11%.

----------

BROKER RATING CHANGES

----------

DZ BANK RAISES FAIR VALUE FOR BT GROUP TO 210 (185) PENCE - 'BUY'

----------

LIBERUM CUTS HOWDEN JOINERY GROUP TO 'HOLD' ('BUY') - TARGET 810 (800) PENCE

----------

COMPANIES - FTSE 100

----------

National Grid said it has filed a three-year rate plan proposal for its Downstate New York businesses. The power line operator, the Department of Public Service Staff and other settling parties have filed a joint proposal for a multi-year rate settlement for National Grid's Downstate New York natural gas distribution businesses, the Brooklyn Union Gas Co and KeySpan Gas East. The proposed settlement is for a three-year rate plan with new rates back-dated to April 2020. A final decision from the New York Public Service Commission is expected later this summer.

----------

Sanofi's and GlaxoSmithKline's adjuvanted recombinant Covid-19 vaccine candidate achieved strong rates of neutralizing antibody responses, the companies reported. The interim results showed 95% to 100% seroconversion following a second injection in patients from 18 to 95 years old and across all doses, with acceptable tolerability and with no safety concerns. Overall, the vaccine candidate elicited strong neutralizing antibody levels that were comparable to those generated by natural infection. The results came from a phase 2 study in all adult age groups with 722 volunteers. A global pivotal phase 3 study is expected to start in the coming weeks, the pharmaceutical companies said.

----------

COMPANIES - FTSE 250

----------

Vistry Group said it has made a positive start to 2021, with strong demand across all areas of the business and an average weekly private sales rate of 0.75, up 70% at the same time in 2020. For the full year, Vistry said housebuilding is on track to deliver a significant step-up in completions to 6,500 units, up from 4,652 in 2020 and ahead of previous guidance. Vistry said its Partnerships unit expects to deliver significant growth in higher-margin mixed-tenure completions in 2021 and is on track to meet its 2022 targets of GBP1 billion revenue and an adjusted operating margin of 10%. Looking ahead, Vistry said that, due to strong trading in the first half and increased expectations for 2021 house completions, it now expects adjusted pretax profit for 2021 to be GBP325 million, whilst maintaining its expectations for 2022. Vistry had previously guided to adjusted pretax profit of at least GBP310 million.

----------

Diploma said it saw a strong first-half performance and expects its full-year performance ahead of expectations. For the six months to March 31, revenue at the London-based seals and cables maker was up 29% to GBP365.2 million from GBP283.6 million the year before, and pretax profit increased 2% to GBP42.5 million from GBP41.6 million, "due to higher amortisation of acquisition intangibles". Diploma declared an interim dividend of 12.5 pence per share, having skipped its interim payout last year, which it said reflects its "growth outlook and future prospects". Looking ahead, Diploma said: "As a result of the strong trading performance in the first half and positive momentum into the second half, we now expect full-year results significantly ahead of our previous expectations."

----------

easyJet has hired recruitment firm Lygon Group to find a successor to Non-Executive Chair John Barton, Sky News reported on Sunday. Barton has led the board of the low-cost airline since 2013. easyJet has begun approaching potential candidates for chair in recent weeks, Sky said citing "City sources".

----------

COMPANIES - MAIN MARKET, AIM AND OTHER

----------

Immunodiagnostic Systems Holdings has agreed to an all-cash takeover offer from the UK arm of Waltham, Massachusetts-based PerkinElmer. The offer of 382 pence per share is a 44% premium to Friday's closing price of 265.00p. It values the share capital of Immunodiagnostic Systems at GBP110 million and implies an enterprise value of GBP88 million, the two companies said. PerkinElmer has 57.9% support for its offer from IDS shareholders. The stock was up 45% early Monday at 369.75p.

----------

Tungsten West, the owner of a historic tungsten mine in Devon, west England is preparing for a initial public offering on AIM with a GBP100 million valuation, the Sunday Times reported. The Hemerdon mine on the edge of Dartmoor holds one of the biggest tungsten deposits outside of China, the newspaper noted. Tungsten West is hoping to raise up to GBP20 million in equity and a further GBP40 million in debt, according to the Times, adding it is backed by former JP Morgan banker Ian Hannam and Moneysupermarket.com Group co-founder Simon Nixon. The company's chief executive, Max Denning, bought Hemerdon out of receivership in 2019, after previous owner Wolf Minerals ran out of cash, the Times said.

----------

Debenhams shut its doors for the final time in its 243-year history. The historic department store chain closed its remaining 28 stores across the UK for good on Saturday after the company collapsed amid the fallout of the coronavirus pandemic. It closed 21 of its sites across the UK for the final time on Thursday last week. The retailer had suffered slumping sales in recent years as shoppers moved away from traditional department store models. However, the enforced closure of sites during the pandemic was the final straw, resulting in the company falling into administration within weeks of the virus fully hitting the UK.

----------

COMPANIES - GLOBAL

----------

HSBC Holdings has been picked as coordinator for Saudia Arabia's potential first initial public offering of a tech startup, Bloomberg reported. The bank's Saudi unit was hired by Jahez International Co for Information Technology, a food delivery firm founded in 2016. HSBC will be sole financial adviser and global coordinator for the potential IPO on the Saudi stock exchange's secondary market, Bloomberg reported, citing the company. A valuation was not disclosed, although the company raised USD36.5 million in a funding round last year, Bloomberg said. Jahez said it has 2 million customers in Saudi Arabia and processed 20 million orders last year.

----------

Monday's Shareholder Meetings

Bahamas Petroleum Co PLC - EGM re share placing, name change

GCP Asset Backed Income Fund Ltd - AGM

Horizonte Minerals PLC - AGM

Vistry Group PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2013 09:36

Immunodiagnostic Systems Affirms Outlook, Interim Profit Hit By One-Off Costs

Read more
27 Nov 2013 09:14

Wednesday broker round-up UPDATE

Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation. Bellway: Numis upgrades to buy with a target price of 1690p. Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation. Britvic: UBS ups target price from 575p to 600p and keeps a neu

Read more
27 Nov 2013 07:57

AIM IN BRIEF: Albemarle & Bond Sees No Signs Of Recovery

Read more
25 Nov 2013 10:13

UK BROKER RATING CHANGES: Jefferies Raises Easyjet To Buy

Read more
25 Nov 2013 08:00

Monday broker round-up UPDATE

African Barrick Gold: Goldman Sachs ups target price from 110p to 140p, but still recommends selling. Alternative Asset Opps: Westhouse Securities initiates with a buy recommendation. Amino Technology: Northland Capital cuts target price from 110p to 100p and downgrades from buy to hold. Asian Pl

Read more
10 Oct 2013 08:36

Thursday broker round-up UPDATE

Ashmore Group: Canaccord Genuity takes target price from 380p to 400p and retains a hold recommendation. Numis shifts target price from 380p to 390p reiterating its hold recommendation. Ashtead Group: Numis upgrades to add with a target price of 670p. Berkeley Group: Panmure Gordon moves target pr

Read more
10 Oct 2013 08:32

Immunodiagnostic Systems returns to growth in first half

Faster revenue growth from its automatic diagnostic testing technology helped Immunodiagnostic Systems (IDS) return to growth in the first half, with first-half declines in its older manual devices also slower than expected. IDS said total revenues for the six months to September 30th would swell

Read more
10 Oct 2013 07:06

Immunodiagnostic Systems Holdings Expects Half-Year Revenues Of GBP27 Million

Read more
2 Jul 2013 15:41

Ashtead execs sell off awards after share-price surge

Equipment rental business Ashtead has seen a number of board-members sell off their share awards given to them as part of their performance share plan (PSP) in June 2010. Awards given to executives under the PSP vest on the third anniversary of grant subject to continued employment and the achievem

Read more
17 Jun 2013 07:33

Immunodiagnostic Systems revenues shrink

Immunodiagnostic Systems posted reduced revenues, in the wake of tough trading conditions, as it puts in place a strategy to return the group to growth. The Newcastle-upon-Tyne based group, which makes manual and automated specialist diagnostic testing kits and instrumentation for the clinical and

Read more
17 Jun 2013 07:21

Monday broker round-up UPDATE

Antofagasta: UBS reduces target price from 1140p to 1050p, while upgrading from neutral to buy. ARM Holdings: Analysts at Numis have cut their view on the shares to reduce from hold. Associated British Foods: Nomura cuts target price from 1800p to 1650p downgrading to reduce. Atkins: Jefferies u

Read more
12 Jun 2013 07:55

Wednesday broker round-up UPDATE

Aberdeen Asset Management: Canaccord Genuity cuts target price from 460p to 440p, while leaving its buy recommendation unchanged. ASOS: Canaccord Genuity downgrades to hold with a target price of 3400p. BT Group: Credit Suisse increases target price from 300p to 350p and maintains an outperform ra

Read more
10 Apr 2013 08:57

Wednesday broker round-up UPDATE

African Barrick Gold: Westhouse Securities upgrades from sell to neutral with a target price of 195p. Deutsche Bank reduces target price from 340p to 230p keeping its hold rating. African Minerals: Deutsche Bank reduces target price from 620p to 594p and leaves its buy recommendation unaltered. An

Read more
10 Apr 2013 08:53

IDS update proves resilience and cash generation

Revenues from medical diagnostics group Immunodiagnostic Systems to the end of March will be marginally reduced on the previous year but in line with expectations. In a year-end trading update, the Newcastle-upon-Tyne based company said total revenues would hit £49.8m for the year to March 31st, d

Read more
5 Apr 2013 16:55

Belvoir Lettings Chairman sells shares to satisfy institutional demand

Belvoir Lettings, the UK lettings specialist which listed on the AIM market in February last year, announced on Friday that its Executive Chairman and founder had sold a quarter of a million shares in the group in order to help satisfy 'significant institutional demand'. The news comes just a week

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.